Skip to main content
Nabila (Baiti) Bennani, MD, Hematology, Rochester, MN

NabilaNora(Baiti)BennaniMD

Hematology Rochester, MN

Hematologic Oncology

Assistant Professor of Medicine, Mayo College of Medicine

Dr. Bennani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bennani's full profile

Already have an account?

  • Office

    200 1st St SW
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • Corewell Health East Beaumont (Royal Oak)
    Corewell Health East Beaumont (Royal Oak)Fellowship, Hematology and Medical Oncology, 2012 - 2015
  • Cleveland Clinic Foundation/Fairview Hospital
    Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2009 - 2012
  • Mohammed V University Faculty of Medicine and Pharmacy
    Mohammed V University Faculty of Medicine and PharmacyClass of 2001

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2015 - 2025
  • MI State Medical License
    MI State Medical License 2012 - 2016
  • OH State Medical License
    OH State Medical License 2009 - 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma  
    Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood

Abstracts/Posters

  • Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
    N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
    N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
    Nora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships